Your browser doesn't support javascript.
loading
Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B).
Sakai, Hitomi; Tsurutani, Junji; Ozaki, Yukinori; Ishiguro, Hiroshi; Nozawa, Kazuki; Watanabe, Kenichi; Maeda, Shigeto; Yokoe, Takamichi; Imamura, Chiyo K; Matsumoto, Koji; Iwasa, Tsutomu; Chiba, Yasutaka; Takiguchi, Daisuke; Takano, Toshimi.
Afiliación
  • Sakai H; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan sakai-h@med.showa-u.ac.jp.
  • Tsurutani J; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.
  • Ozaki Y; Breast Medical Oncology Department, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ishiguro H; Breast Oncology Service, Saitama Medical University International Medical Center, Saitama, Japan.
  • Nozawa K; Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Watanabe K; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Hokkaido, Japan.
  • Maeda S; Department of Surgery, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
  • Yokoe T; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Imamura CK; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.
  • Matsumoto K; Department of Medical Oncology, Hyogo Cancer Center, Hyogo, Japan.
  • Iwasa T; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Chiba Y; Clinical Research Center, Kindai University Hospital, Osaka, Japan.
  • Takiguchi D; Oncology Medical Science Department, Daiichi Sankyo Co Ltd, Tokyo, Japan.
  • Takano T; Breast Medical Oncology Department, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
BMJ Open ; 13(4): e070304, 2023 04 03.
Article en En | MEDLINE | ID: mdl-37012013
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inmunoconjugados / Antieméticos / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Female / Humans Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inmunoconjugados / Antieméticos / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Female / Humans Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido